A new review maps how gut microbes and their metabolites bidirectionally shape T cell immunity to drive autoimmune, ...
Cancer-fighting T cells can lose their edge after prolonged exposure to tumors. New research from Memorial Sloan Kettering ...
Immunotherapies, especially CAR T-cell therapy, have fundamentally changed cancer treatment in recent years, particularly for ...
When you hear that 'immunity declines with age,' don't you imagine the body's protective power gradually dwindling?However, a ...
Autoimmune liver diseases (AILDs), including autoimmune hepatitis, primary biliary cholangitis, primary sclerosing ...
Plasma-derived small extracellular vesicles from head and neck cancer patients suppress T-cell proliferation, trigger ...
Meditope technology provides an orthogonal ligand-receptor pair: an engineered fragment antigen-binding (Fab) binds a 12-amino-acid cyclic meP (sequence: CQFDLSTRRLKC) without disrupting antigen ...
Using microscopic silicon nanowires, Singh and his team delivered the instructions into more than 90% of aging T cells without damaging them. The goal wasn't to reverse aging. It was to restore enough ...
Cancer immunotherapy can lose its punch when tumor-fighting T cells become exhausted, but researchers may have found a way to keep them going longer. Scientists at Memorial Sloan Kettering Cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results